Growth Factors: Avenues for the Treatment of Myocardial Infarction and Potential Delivery Strategies

References

• Shi N , MeiX , ChenSY. Smooth muscle cells in vascular remodeling. Arterioscler. Thromb. Vasc. Biol.39(12), e247–e252 (2019).
   PubMed Web of Science ®Google Scholar
• Liu L , SongS , ZhangYPet al. Amphiregulin promotes cardiac fibrosis post myocardial infarction by inducing the endothelial-mesenchymal transition via the EGFR pathway in endothelial cells. Exp. Cell Res.390(2), 111950 (2020).
   PubMed Web of Science ®Google Scholar
• Wu QQ , XiaoY , YuanYet al. Mechanisms contributing to cardiac remodelling. Clin. Sci. (Lond.)131(18), 2319–2345 (2017).
   PubMed Web of Science ®Google Scholar
• Nallamothu BK , BradleyEH , KrumholzHM. Current concepts – time to treatment in primary percutaneous coronary intervention. N. Engl. J. Med.357(16), 1631–1638 (2007).
   PubMed Web of Science ®Google Scholar
• Dangas G , IakovouI , NikolskyEet al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am. J. Cardiol.95(1), 13–19 (2005).
   PubMed Web of Science ®Google Scholar
• Best PJM , LennonR , TingHHet al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J. Am. Coll. Cardiol.39(7), 1113–1119 (2002).
   PubMed Web of Science ®Google Scholar
• Taylor DA , ZenovichAG. Cardiovascular cell therapy and endogenous repair. Diabetes Obes. Metab.10, 5–15 (2008).
   PubMed Web of Science ®Google Scholar
• Jeevanantham V , ButlerM , SaadA , Abdel-LatifA , Zuba-SurmaEK , DawnB. Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis. Circulation126(5), 551–568 (2012).
   PubMed Web of Science ®Google Scholar
• Ye L , HaiderHK , TanRet al. Transplantation of nanoparticle transfected skeletal myoblasts overexpressing vascular endothelial growth factor-165 for cardiac repair. Circulation116(11 Suppl.), I113–I120 (2007).
   PubMed Web of Science ®Google Scholar
• Tang JN , CuiXL , CaranasosTGet al. Heart repair using nanogel-encapsulated human cardiac stem cells in mice and pigs with myocardial infarction. ACS Nano11(10), 9738–9749 (2017).
   PubMed Web of Science ®Google Scholar
• Li TS , ChengK , MalliarasKet al. Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells. J. Am. Coll. Cardiol.59(10), 942–953 (2012).
   PubMed Web of Science ®Google Scholar
• Fisher SA , ZhangHJ , DoreeC , MathurA , Martin-RendonE. Stem cell treatment for acute myocardial infarction. Cochrane Database Syst. Rev.2015(9), CD006536 (2015).
   PubMedGoogle Scholar
• Fisher SA , DoreeC , MathurA , TaggartDP , Martin-RendonE. Stem cell therapy for chronic ischaemic heart disease and congestive heart failure. Cochrane Database Syst. Rev.12(12), CD007888 (2016).
   PubMedGoogle Scholar
• Andrews PW , MatinMM , BahramiAR , DamjanovI , GokhaleP , DraperJS. Embryonic stem (ES) cells and embryonal carcinoma (EC) cells: opposite sides of the same coin. Biochem. Soc. Trans.33, 1526–1530 (2005).
   PubMed Web of Science ®Google Scholar
• Heslop JA , HammondTG , SanteramoIet al. Concise review: workshop review: understanding and assessing the risks of stem cell-based therapies. Stem Cells Transl. Med.4(4), 389–400 (2015).
   PubMed Web of Science ®Google Scholar
• Malliaras K , LiTS , LuthringerDet al. Safety and efficacy of allogeneic cell therapy in infarcted rats transplanted with mismatched cardiosphere-derived cells. Circulation125(1), 100–112 (2012).
   PubMed Web of Science ®Google Scholar
• Shamsul BS , AminuddinBS , NgMHA , RuszymahBHI. Age and gender effect on the growth of bone marrow stromal cells in vitro. Med. J. Malaysia59(Suppl. B), 196–197 (2004).
   PubMedGoogle Scholar
• Conley SM , HicksonLJ , KelloggTAet al. Human obesity induces dysfunction and early senescence in adipose tissue-derived mesenchymal stromal/stem cells. Front. Cell Dev. Biol.8, 197 (2020).
   PubMed Web of Science ®Google Scholar
• Lefer DJ , MarbanE. Is cardioprotection dead?Circulation136(1), 98–109 (2017).
   PubMed Web of Science ®Google Scholar
• Tang XL , RokoshG , SanganalmathSKet al. Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation121(2), 293–305 (2010).
   PubMed Web of Science ®Google Scholar
• Cui X , TangJ , HartantoYet al. NIPAM-based microgel microenvironment regulates the therapeutic function of cardiac stromal cells. ACS Appl. Mater. Interfaces10(44), 37783–37796 (2018).
   PubMed Web of Science ®Google Scholar
• Li Q , HouH , LiMet al. CD73(+) mesenchymal stem cells ameliorate myocardial infarction by promoting angiogenesis. Front. Cell Dev. Biol.9, 637239 (2021).
   PubMed Web of Science ®Google Scholar
• Nagaya N , KangawaK , ItohTet al. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation112(8), 1128–1135 (2005).
   PubMed Web of Science ®Google Scholar
• Mathieu M , BartunekJ , ElOumeiri Bet al. Cell therapy with autologous bone marrow mononuclear stem cells is associated with superior cardiac recovery compared with use of nonmodified mesenchymal stem cells in a canine model of chronic myocardial infarction. J. Thorac. Cardiovasc. Surg.138(3), 646–653 (2009).
   PubMed Web of Science ®Google Scholar
• Askari AT , UnzekS , PopovicZBet al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet362(9385), 697–703 (2003).
   PubMed Web of Science ®Google Scholar
• Urbich C , AicherA , HeeschenCet al. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J. Mol. Cell. Cardiol.39(5), 733–742 (2005).
   PubMed Web of Science ®Google Scholar
• Shintani Y , FukushimaS , Varela-CarverAet al. Donor cell-type specific paracrine effects of cell transplantation for post-infarction heart failure. J. Mol. Cell. Cardiol.47(2), 288–295 (2009).
   PubMed Web of Science ®Google Scholar
• Fei Q , MaH , ZouJet al. Metformin protects against ischaemic myocardial injury by alleviating autophagy-ROS-NLRP3-mediated inflammatory response in macrophages. J. Mol. Cell. Cardiol.145, 1–13 (2020).
   PubMed Web of Science ®Google Scholar
• Ong SB , Hernandez-ResendizS , Crespo-AvilanGEet al. Inflammation following acute myocardial infarction: multiple players, dynamic roles, and novel therapeutic opportunities. Pharmacol. Ther.186, 73–87 (2018).
   PubMed Web of Science ®Google Scholar
• Zou J , FeiQ , XiaoHet al. VEGF-A promotes angiogenesis after acute myocardial infarction through increasing ROS production and enhancing ER stress-mediated autophagy. J. Cell. Physiol.234(10), 17690–17703 (2019).
   PubMed Web of Science ®Google Scholar
• Hernandez-Resendiz S , ChindaK , OngSB , Cabrera-FuentesH , ZazuetaC , HausenloyDJ. The role of redox dysregulation in the inflammatory response to acute myocardial ischaemia-reperfusion injury – adding fuel to the fire. Curr. Med. Chem.25(11), 1275–1293 (2018).
   PubMed Web of Science ®Google Scholar
• Loguinova M , PineginaN , KoganVet al. Monocytes of different subsets in complexes with platelets in patients with myocardial infarction. Thromb. Haemost.118(11), 1969–1981 (2018).
   PubMed Web of Science ®Google Scholar
• Rainger GE , ChimenM , HarrisonMJet al. The role of platelets in the recruitment of leukocytes during vascular disease. Platelets26(6), 507–520 (2015).
   PubMed Web of Science ®Google Scholar
• Kim Y , NurakhayevS , NurkeshA , ZharkinbekovZ , SaparovA. Macrophage polarization in cardiac tissue repair following myocardial infarction. Int. J. Mol. Sci.22(5), 2751 (2021).
   PubMed Web of Science ®Google Scholar
• Peet C , IveticA , BromageDI , ShahAM. Cardiac monocytes and macrophages after myocardial infarction. Cardiovasc. Res.116(6), 1101–1112 (2020).
   PubMed Web of Science ®Google Scholar
• Ibarra-Lara L , Sanchez-AguilarM , Soria-CastroEet al. Clofibrate treatment decreases inflammation and reverses myocardial infarction-induced remodelation in a rodent experimental model. Molecules24(2), 270 (2019).
   PubMed Web of Science ®Google Scholar
• Clerc OF , HaafP , BuechelRR , GaemperliO , ZellwegerMJ. New therapies to modulate post-infarction inflammatory alterations in the myocardium: state of the art and forthcoming applications. Curr. Radiopharm.14(3), 273–299 (2021).
   PubMed Web of Science ®Google Scholar
• Frangogiannis NG . Regulation of the inflammatory response in cardiac repair. Circ. Res.110(1), 159–173 (2012).
   PubMed Web of Science ®Google Scholar
• Ip WKE , HoshiN , ShouvalDS , SnapperS , MedzhitovR. Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages. Science356(6337), 513–519 (2017).
   PubMed Web of Science ®Google Scholar
• Dobaczewski M , ChenW , FrangogiannisNG. Transforming growth factor (TGF)-β signaling in cardiac remodeling. J. Mol. Cell. Cardiol.51(4), 600–606 (2011).
   PubMed Web of Science ®Google Scholar
• Chen W , FrangogiannisNG. Fibroblasts in post-infarction inflammation and cardiac repair. Biochim. Biophys. Acta1833(4), 945–953 (2013).
   PubMed Web of Science ®Google Scholar
• Yang Z , WanJ , PanW , ZouJ. Expression of vascular endothelial growth factor in cardiac repair: signaling mechanisms mediating vascular protective effects. Int. J. Biol. Macromol.113, 179–185 (2018).
   PubMed Web of Science ®Google Scholar
• Rong SL , WangXL , WangYCet al. Anti-inflammatory activities of hepatocyte growth factor in post-ischemic heart failure. Acta Pharmacol. Sin.39(10), 1613–1621 (2018).
   PubMed Web of Science ®Google Scholar
• Madonna R , PetrovL , TeberinoMAet al. Transplantation of adipose tissue mesenchymal cells conjugated with VEGF-releasing microcarriers promotes repair in murine myocardial infarction. Cardiovasc. Res.108(1), 39–49 (2015).
   PubMed Web of Science ®Google Scholar
• Bourron O , LeBouc Y , BerardLet al. Impact of age-adjusted insulin-like growth factor 1 on major cardiovascular events after acute myocardial infarction: results from the FAST-MI registry. J. Clin. Endocrinol. Metab.100(5), 1879–1886 (2015).
   PubMed Web of Science ®Google Scholar
• Heinen A , NederlofR , PanjwaniPet al. IGF1 treatment improves cardiac remodeling after infarction by targeting myeloid cells. Mol. Ther.27(1), 46–58 (2019).
   PubMed Web of Science ®Google Scholar
• Lin M , LiuX , ZhengHet al. IGF-1 enhances BMSC viability, migration, and anti-apoptosis in myocardial infarction via secreted frizzled-related protein 2 pathway. Stem Cell Res. Ther.11(1), 22 (2020).
   PubMed Web of Science ®Google Scholar
• Zhang A , HuJ , XuZ , WangC , BianL. TNF-alpha and IL-18 as diagnostic markers for acute myocardial infarction (AMI) and risk factors for AMI-related death. Int. J. Clin. Exp. Med.13(8), 5941–5949 (2020).
   Web of Science ®Google Scholar
• O’Brien LC , MezzaromaE , Van TassellBWet al. Interleukin-18 as a therapeutic target in acute myocardial infarction and heart failure. Mol. Med.20, 221–229 (2014).
   PubMed Web of Science ®Google Scholar
• Venkatachalam K , PrabhuSD , ReddyVS , BoylstonWH , ValenteAJ , ChandrasekarB. Neutralization of interleukin-18 ameliorates ischemia/reperfusion-induced myocardial injury. J. Biol. Chem.284(12), 7853–7865 (2009).
   PubMed Web of Science ®Google Scholar
• Gu H , XieM , XuL , ZhengX , YangY , LvX. The protective role of interleukin-18 binding protein in a murine model of cardiac ischemia/reperfusion injury. Transpl. Int.28(12), 1436–1444 (2015).
   PubMed Web of Science ®Google Scholar
• Edlinger C , WernlyB , LeischMet al. Analysis of ambient influences affecting interleukin-6 secretion in the context of clinical trials of stem cell therapy for myocardial infarction. Clin. Lab.62(6), 1061–1068 (2016).
   PubMed Web of Science ®Google Scholar
• Neri M , FineschiV , DiPaolo Met al. Cardiac oxidative stress and inflammatory cytokines response after myocardial infarction. Curr. Vasc. Pharmacol.13(1), 26–36 (2015).
   PubMed Web of Science ®Google Scholar
• Wilkowska A , PikulaM , RynkiewiczA , Wdowczyk-SzulcJ , TrzonkowskiP , LandowskiJ. Increased plasma pro-inflammatory cytokine concentrations after myocardial infarction and the presence of depression during next 6-months. Psychiatr. Pol.49(3), 455–464 (2015).
   PubMed Web of Science ®Google Scholar
• Fanola CL , MorrowDA , CannonCPet al. Interleukin-6 and the risk of adverse outcomes in patients after an acute coronary syndrome: observations from the SOLID-TIMI 52 (Stabilization of Plaque Using Darapladib–Thrombolysis in Myocardial Infarction 52) trial. J. Am. Heart Assoc.6(10), e005637 (2017).
   PubMed Web of Science ®Google Scholar
• Jong WMC , TenCate H , LinnenbankACet al. Reduced acute myocardial ischemia–reperfusion injury in IL-6-deficient mice employing a closed-chest model. Inflamm. Res.65(6), 489–499 (2016).
   PubMed Web of Science ®Google Scholar
• Orrem HL , NilssonPH , PischkeSEet al. IL-6 receptor inhibition by tocilizumab attenuated expression of C5a receptor 1 and 2 in non-ST-elevation myocardial infarction. Front. Immunol.9, 2037 (2018).
   PubMed Web of Science ®Google Scholar
• Shahrivari M , WiseE , ResendeMet al. Peripheral blood cytokine levels after acute myocardial infarction IL-1β- and IL-6-related impairment of bone marrow function. Circ. Res.120(12), 1947–1957 (2017).
   PubMed Web of Science ®Google Scholar
• Cen W , ChenZ , GuN , HoppeR. Prevention of AMI induced ventricular remodeling: inhibitory effects of heart-protecting musk pill on IL-6 and TNF-alpha. Evid. Based Complement. Alternat. Med.2017, 3217395 (2017).
   PubMed Web of Science ®Google Scholar
• Jung M , MaY , IyerRPet al. IL-10 improves cardiac remodeling after myocardial infarction by stimulating M2 macrophage polarization and fibroblast activation. Basic Res. Cardiol.112(3), 33 (2017).
   PubMed Web of Science ®Google Scholar
• Cihakova D . Interleukin-10 stiffens the heart. J. Exp. Med.215(2), 379–381 (2018).
   PubMed Web of Science ®Google Scholar
• Cambier L , DeCouto G , IbrahimAet al. RNA fragment in extracellular vesicles confers cardioprotection via modulation of IL-10 expression and secretion. EMBO Mol. Med.9(3), 337–352 (2017).
   PubMed Web of Science ®Google Scholar
• Meng D , HanS , JeongIS , KimSW. Interleukin 10-secreting MSCs via TALEN-mediated gene editing attenuates left ventricular remodeling after myocardial infarction. Cell. Physiol. Biochem.52(4), 728–741 (2019).
   PubMedGoogle Scholar
• Pickup MW , OwensP , MosesHL. TGF-β, bone morphogenetic protein, and activin signaling and the tumor microenvironment. Cold Spring Harb. Perspect. Biol.9(5), a022285 (2017).
   PubMed Web of Science ®Google Scholar
• Lu Q , WangWW , ZhangMZet al. ROS induces epithelial-mesenchymal transition via the TGF-1/PI3K/Akt/mTOR pathway in diabetic nephropathy. Exp. Ther. Med.17(1), 835–846 (2019).
   PubMed Web of Science ®Google Scholar
• Zhang S , CheD , YangFet al. Tumor-associated macrophages promote tumor metastasis via the TGF-β/SOX9 axis in non-small cell lung cancer. Oncotarget8(59), 99801–99815 (2017).
   PubMedGoogle Scholar
• Frangogiannis NG . The role of transforming growth factor (TGF)-β in the infarcted myocardium. J. Thorac. Dis.9, S52–S63 (2017).
   PubMed Web of Science ®Google Scholar
• Goumans MJ , TenDijke P. TGF-β signaling in control of cardiovascular function. Cold Spring Harb. Perspect. Biol.10(2), a022210 (2018).
   PubMed Web of Science ®Google Scholar
• Zhang XG , WeiY , JiangJ , WangL , LiangHY , LeiCB. Effect of TGF-β1 on myocardial cell apoptosis in rats with acute myocardial infarction via MAPK signaling pathway. Eur. Rev. Med. Pharmacol. Sci.24(3), 1350–1356 (2020).
   PubMed Web of Science ®Google Scholar
• Dergilev KV , TsokolaevaZI , BeloglazovaIB , RatnerEI , ParfenovaEV. Transforming growth factor beta (TGF-β1) induces pro-reparative phenotypic changes in epicardial cells in mice. Bull. Exp. Biol. Med.170(4), 565–570 (2021).
   PubMed Web of Science ®Google Scholar
• Wu L , ChenG , SongJ. Association between TGF-β1-913G/C polymorphism and myocardial infarction risk in a Chinese Han population: a case–control study. Biosci. Rep.39, BSR20190315 (2019).
   PubMedGoogle Scholar
• Zhang Z , LongC , GuanY , SongM. Hepatocyte growth factor intervention to reduce myocardial injury and improve cardiac function on diabetic myocardial infarction rats. Eur. J. Histochem.64, 3124 (2020).
   PubMed Web of Science ®Google Scholar
• Wang LS , WangH , ZhangQL , YangZJ , KongFX , WuCT. Hepatocyte growth factor gene therapy for ischemic diseases. Hum. Gene Ther.29(4), 413–423 (2018).
   PubMed Web of Science ®Google Scholar
• Meng H , BoC , TaoZet al. Safety and efficacy of adenovirus carrying hepatocyte growth factor gene by percutaneous endocardial injection for treating post-infarct heart failure: a phase IIa clinical trial. Curr. Gene Ther.18(2), 125–130 (2018).
   PubMed Web of Science ®Google Scholar
• Gallo S , SalaV , GattiS , CrepaldiT. Cellular and molecular mechanisms of HGF/Met in the cardiovascular system. Clin. Sci.129(12), 1173–1193 (2015).
   PubMed Web of Science ®Google Scholar
• Itoh N , OhtaH , NakayamaY , KonishiM. Roles of FGF signals in heart development, health, and disease. Front. Cell Dev. Biol.4, 110 (2016).
   PubMed Web of Science ®Google Scholar
• Rao Z , ShenD , ChenJet al. Basic fibroblast growth factor attenuates injury in myocardial infarction by enhancing hypoxia-inducible factor-1 alpha accumulation. Front. Pharmacol.11, 1193 (2020).
   PubMed Web of Science ®Google Scholar
• Yamasaki S , NabeshimaK , SotomaruYet al. Long-term serial cultivation of mouse induced pluripotent stem cells in serum-free and feeder-free defined medium. Int. J. Dev. Biol.57(9–10), 715–724 (2013).
   PubMed Web of Science ®Google Scholar
• Singla DK , SinglaRD , AbdelliLS , GlassC. Fibroblast growth factor-9 enhances M2 macrophage differentiation and attenuates adverse cardiac remodeling in the infarcted diabetic heart. PLoS One10(3), e0120739 (2015).
   PubMed Web of Science ®Google Scholar
• Ruperez C , LerinC , Ferrer-CurriuGet al. Autophagic control of cardiac steatosis through FGF21 in obesity-associated cardiomyopathy. Int. J. Cardiol.260, 163–170 (2018).
   PubMed Web of Science ®Google Scholar
• Gomez-Samano MA , Grajales-GomezM , Zuarth-VazquezJMet al. Fibroblast growth factor 21 and its novel association with oxidative stress. Redox Biol.11, 335–341 (2017).
   PubMed Web of Science ®Google Scholar
• Yan X , ChenJ , ZhangCet al. FGF21 deletion exacerbates diabetic cardiomyopathy by aggravating cardiac lipid accumulation. J. Cell. Mol. Med.19(7), 1557–1568 (2015).
   PubMed Web of Science ®Google Scholar
• Pan X , ShaoY , WuFet al. FGF21 prevents angiotensin II-induced hypertension and vascular dysfunction by activation of ACE2/angiotensin-(1–7) axis in mice. Cell Metab.27(6), 1323–1337.e5 (2018).
   PubMed Web of Science ®Google Scholar
• Bergmark BA , UdellJA , MorrowDAet al. Association of fibroblast growth factor 23 with recurrent cardiovascular events in patients after an acute coronary syndrome: a secondary analysis of a randomized clinical trial. JAMA Cardiol.3(6), 473–480 (2018).
   PubMed Web of Science ®Google Scholar
• Fuernau G , PoessJ , DenksDet al. Fibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial. Crit. Care18(6), 713 (2014).
   PubMed Web of Science ®Google Scholar
• Ziff OJ , BromageDI , YellonDM , DavidsonSM. Therapeutic strategies utilizing SDF-1 alpha in ischaemic cardiomyopathy. Cardiovasc. Res.114(3), 358–367 (2018).
   PubMed Web of Science ®Google Scholar
• Gong XH , LiuH , WangSJ , LiangSW , WangGG. Exosomes derived from SDF1-overexpressing mesenchymal stem cells inhibit ischemic myocardial cell apoptosis and promote cardiac endothelial microvascular regeneration in mice with myocardial infarction. J. Cell. Physiol.234(8), 13878–13893 (2019).
   PubMed Web of Science ®Google Scholar
• Goldstone AB , BurnettCE , CohenJEet al. SDF 1-alpha attenuates myocardial injury without altering the direct contribution of circulating cells. J. Cardiovasc. Transl. Res.11(4), 274–284 (2018).
   PubMed Web of Science ®Google Scholar
• Huang FY , XiaTL , LiJLet al. The bifunctional SDF-1-AnxA5 fusion protein protects cardiac function after myocardial infarction. J. Cell. Mol. Med.23(11), 7673–7684 (2019).
   PubMed Web of Science ®Google Scholar
• Su G , LiuL , YangL , MuY , GuanL. Homing of endogenous bone marrow mesenchymal stem cells to rat infarcted myocardium via ultrasound-mediated recombinant SDF-1 alpha adenovirus in microbubbles. Oncotarget9(1), 477–487 (2018).
   PubMedGoogle Scholar
• Chung ES , MillerL , PatelANet al. Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized phase II trial. Eur. Heart J.36(33), 2228–2238 (2015).
   PubMed Web of Science ®Google Scholar
• Cacciapuoti M , JohnsonB , KapdiaA , PowellS , GallicanoGI. The role of neuregulin and stem cells as therapy post-myocardial infarction. Stem Cells Dev.29(19), 1266–1274 (2020).
   PubMed Web of Science ®Google Scholar
• Lin Y , LiuH , WangX. Neuregulin-1, a microvascular endothelial-derived protein, protects against myocardial ischemia–reperfusion injury (review). Int. J. Mol. Med.46(3), 925–935 (2020).
   PubMed Web of Science ®Google Scholar
• Dugaucquier L , FeyenE , MateiuL , BruynsTAM , DeKeulenaer GW , SegersVFM. The role of endothelial autocrine NRG1/ERBB4 signaling in cardiac remodeling. Am. J. Physiol. Heart Circ. Physiol.319(2), H443–H455 (2020).
   PubMed Web of Science ®Google Scholar
• Miao J , HuangS , SuYRet al. Effects of endogenous serum neuregulin-1 on morbidity and mortality in patients with heart failure and left ventricular systolic dysfunction. Biomarkers23(7), 704–708 (2018).
   PubMed Web of Science ®Google Scholar
• Ganapathy B , NandhagopalN , PolizzottiBDet al. Neuregulin-1 administration protocols sufficient for stimulating cardiac regeneration in young mice do not induce somatic, organ, or neoplastic growth. PLoS One11(5), e0155456 (2016).
   PubMed Web of Science ®Google Scholar
• Yang G , WuC , LiLet al. Neuregulin-1 protects cardiac electrical conduction through downregulating matrix metalloproteinase-9 and upregulating connexin 43 in a rat myocardial infarction model. Pharmazie74(4), 231–234 (2019).
   PubMed Web of Science ®Google Scholar
• Rao P , LiuZ , DuanHet al. Pretreatment with neuregulin-1 improves cardiac electrophysiological properties in a rat model of myocardial infarction. Exp. Ther. Med.17(4), 3141–3149 (2019).
   PubMed Web of Science ®Google Scholar
• Cohen JE , GoldstoneAB , WangHet al. A bioengineered neuregulin–hydrogel therapy reduces scar size and enhances post-infarct ventricular contractility in an ovine large animal model. J. Cardiovasc. Dev. Dis.7(4), 53 (2020).
   PubMed Web of Science ®Google Scholar
• Epstein SE , KornowskiR , FuchsS , DvorakHF. Angiogenesis therapy – amidst the hype, the neglected potential for serious side effects. Circulation104(1), 115–119 (2001).
   PubMed Web of Science ®Google Scholar
• Inoue M , ItohH , UedaMet al. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions – possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation98(20), 2108–2116 (1998).
   PubMed Web of Science ®Google Scholar
• Lee RJ , SpringerML , Blanco-BoseWE , ShawR , UrsellPC , BlauHM. VEGF gene delivery to myocardium – deleterious effects of unregulated expression. Circulation102(8), 898–901 (2000).
   PubMed Web of Science ®Google Scholar
• Liu G , LiL , HuoDet al. A VEGF delivery system targeting MI improves angiogenesis and cardiac function based on the tropism of MSCs and layer-by-layer self-assembly. Biomaterials127, 117–131 (2017).
   PubMed Web of Science ®Google Scholar
• Scott RC , RosanoJM , IvanovZet al. Targeting VEGF-encapsulated immunoliposomes to MI heart improves vascularity and cardiac function. FASEB J.23(10), 3361–3367 (2009).
   PubMed Web of Science ®Google Scholar
• Awada HK , HwangMTP , WangYD. Towards comprehensive cardiac repair and regeneration after myocardial infarction: aspects to consider and proteins to deliver. Biomaterials82, 94–112 (2016).
   PubMed Web of Science ®Google Scholar
• Fan C , ShiJ , ZhuangYet al. Myocardial-infarction-responsive smart hydrogels targeting matrix metalloproteinase for on-demand growth factor delivery. Adv. Mater.31(40), e1902900 (2019).
   PubMed Web of Science ®Google Scholar
• Atienza-Roca P , KieserDC , CuiXet al. Visible light mediated PVA–tyramine hydrogels for covalent incorporation and tailorable release of functional growth factors. Biomater. Sci.8(18), 5005–5019 (2020).
   PubMed Web of Science ®Google Scholar
• Yuan Z , TsouYH , ZhangXQet al. Injectable citrate-based hydrogel as an angiogenic biomaterial improves cardiac repair after myocardial infarction. ACS Appl. Mater. Interfaces11(42), 38429–38439 (2019).
   PubMed Web of Science ®Google Scholar
• Feng J , WuY , ChenWet al. Sustained release of bioactive IGF-1 from a silk fibroin microsphere-based injectable alginate hydrogel for the treatment of myocardial infarction. J. Mater. Chem. B8(2), 308–315 (2020).
   PubMed Web of Science ®Google Scholar
• Saludas L , Pascual-GilS , RoliF , GarbayoE , Blanco-PrietoMJ. Heart tissue repair and cardioprotection using drug delivery systems. Maturitas110, 1–9 (2018).
   PubMed Web of Science ®Google Scholar
• Qi Q , LuL , LiHQet al. Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction. Int. J. Nanomedicine12, 4835–4848 (2017).
   PubMed Web of Science ®Google Scholar
• Formiga FR , PelachoB , GarbayoEet al. Sustained release of VEGF through PLGA microparticles improves vasculogenesis and tissue remodeling in an acute myocardial ischemia–reperfusion model. J. Control. Release147(1), 30–37 (2010).
   PubMed Web of Science ®Google Scholar
• Chang MY , YangYJ , ChangCHet al. Functionalized nanoparticles provide early cardioprotection after acute myocardial infarction. J. Control. Rel.170(2), 287–294 (2013).
   PubMed Web of Science ®Google Scholar
• Davis ME , HsiehPCH , TakahashiTet al. Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction. Proc. Natl Acad. Sci. U. S. A.103(21), 8155–8160 (2006).
   PubMed Web of Science ®Google Scholar
• Hsieh PCH , DavisME , GannonJ , MacGillivrayC , LeeRT. Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers. J. Clin. Invest.116(1), 237–248 (2006).
   PubMed Web of Science ®Google Scholar
• Kim JH , JungY , KimSHet al. The enhancement of mature vessel formation and cardiac function in infarcted hearts using dual growth factor delivery with self-assembling peptides. Biomaterials32(26), 6080–6088 (2011).
   PubMed Web of Science ®Google Scholar
• Yin R , YangD , WuH , HuangK , WuX , ChenY. Intramyocardial injection of vascular endothelial growth factor gene improves cardiac performance and inhibits cardiomyocyte apoptosis. Eur. J. Heart Fail.9(4), 343–351 (2007).
   PubMed Web of Science ®Google Scholar
• Wu X , WangD , QinKet al. Cardiac repair with echocardiography-guided multiple percutaneous left ventricular intramyocardial injection of hiPSC-CMs after myocardial infarction. Front. Cardiovasc. Med.8, 768873 (2021).
   PubMed Web of Science ®Google Scholar
• Maslov M , FoianiniS , LovichM. Delivery of drugs, growth factors, genes and stem cells via intrapericardial, epicardial and intramyocardial routes for sustained local targeted therapy of myocardial disease. Expert Opin. Drug Deliv.14(10), 1227–1239 (2017).
   PubMed Web of Science ®Google Scholar
• Mei X , ChengK. Recent development in therapeutic cardiac patches. Front. Cardiovasc. Med.7, 610364 (2020).
   PubMed Web of Science ®Google Scholar
• Yang SY , O’CearbhaillED , SiskGCet al. A bio-inspired swellable microneedle adhesive for mechanical interlocking with tissue. Nat. Commun.4, 1702 (2013).
   PubMed Web of Science ®Google Scholar
• Lakshmanan R , KumaraswamyP , KrishnanUM , SethuramanS. Engineering a growth factor embedded nanofiber matrix niche to promote vascularization for functional cardiac regeneration. Biomaterials97, 176–195 (2016).
   PubMed Web of Science ®Google Scholar
• Park BW , JungSH , DasSet al. In vivo priming of human mesenchymal stem cells with hepatocyte growth factor-engineered mesenchymal stem cells promotes therapeutic potential for cardiac repair. Sci. Adv.6(13), eaay6994 (2020).
   PubMed Web of Science ®Google Scholar
• Shi H , XueT , YangYet al. Microneedle-mediated gene delivery for the treatment of ischemic myocardial disease. Sci. Adv.6(25), eaaz3621 (2020).
   PubMed Web of Science ®Google Scholar
• Tang J , WangJ , HuangKet al. Cardiac cell-integrated microneedle patch for treating myocardial infarction. Sci. Adv.4(11), eaat9365 (2018).
   PubMed Web of Science ®Google Scholar
• Bar A , CohenS. Inducing endogenous cardiac regeneration: can biomaterials connect the dots?Front. Bioeng. Biotechnol.8, 126 (2020).
   PubMed Web of Science ®Google Scholar
• Edelman ER , NugentMA , KarnovskyMJ. Perivascular and intravenous administration of basic fibroblast growth factor: vascular and solid organ deposition. Proc. Natl Acad. Sci. USA90(4), 1513–1517 (1993).
   PubMed Web of Science ®Google Scholar
• Qiao B , NieJJ , ShaoYet al. Functional nanocomplexes with vascular endothelial growth factor A/C isoforms improve collateral circulation and cardiac function. Small16(4), e1905925 (2020).
   PubMed Web of Science ®Google Scholar
• Kim H , YunN , MunDet al. Cardiac-specific delivery by cardiac tissue-targeting peptide-expressing exosomes. Biochem. Biophys. Res. Commun.499(4), 803–808 (2018).
   PubMed Web of Science ®Google Scholar
• Su T , HuangK , MaHet al. Platelet-inspired nanocells for targeted heart repair after ischemia/reperfusion injury. Adv. Funct. Mater.29(4), 1803567 (2019).
   PubMed Web of Science ®Google Scholar
• Tang J , CuiX , ZhangZet al. Injection-free delivery of MSC-derived extracellular vesicles for myocardial infarction therapeutics. Adv. Healthc. Mater.11(5), e2100312 (2022).
   PubMed Web of Science ®Google Scholar
• Mori D , MiyagawaS , YajimaSet al. Cell spray transplantation of adipose-derived mesenchymal stem cell recovers ischemic cardiomyopathy in a porcine model. Transplantation102(12), 2012–2024 (2018).
   PubMed Web of Science ®Google Scholar
• Miragoli M , CeriottiP , IafiscoMet al. Inhalation of peptide-loaded nanoparticles improves heart failure. Sci. Transl. Med.10(424), eaan6205 (2018).
   PubMed Web of Science ®Google Scholar
• Richards DJ , LiY , KerrCMet al. Human cardiac organoids for the modelling of myocardial infarction and drug cardiotoxicity. Nat. Biomed. Eng.4(4), 446–462 (2020).
   PubMedGoogle Scholar
• Yang X , ZhangY , HosakaKet al. VEGF-B promotes cancer metastasis through a VEGF-A-independent mechanism and serves as a marker of poor prognosis for cancer patients. Proc. Natl Acad. Sci. U. S. A.112(22), e2900–e2909 (2015).
   PubMed Web of Science ®Google Scholar
• Hao H , MaS , ZhengCet al. Excessive fibroblast growth factor 23 promotes renal fibrosis in mice with type 2 cardiorenal syndrome. Aging (Albany NY)13(2), 2982–3009 (2021).
   PubMedGoogle Scholar
• Kim YS , LeeHJ , HanMH , YoonNK , KimYC , AhnJ. Effective production of human growth factors in Escherichia coli by fusing with small protein 6HFh8. Microb. Cell Fact.20(1), 9 (2021).
   PubMed Web of Science ®Google Scholar